FAQ

A hair transplant is the transfer of natural hair follicles from the back of the scalp to thinning areas, producing permanent growth. Unlike wigs or hairpieces, it provides a long-term solution rather than temporary coverage.

A permanent hair transplant (Hair Transplant Surgery) involves relocating living hair follicles from the occipital or parietal regions of the scalp—areas genetically resistant to dihydrotestosterone (DHT)—into bald or thinning zones. These follicles will continue to grow naturally and remain long-lasting. In contrast, wigs or hairpieces are external fibers that do not grow, require maintenance, and need replacement, offering only temporary concealment.

Hair transplantation is performed under local anesthesia, not general anesthesia. It causes minimal discomfort, is safe, and requires only a short recovery period.

Modern techniques such as Follicular Unit Extraction (FUE) or Long Hair FUE utilize local anesthetic infiltration. Patients may feel slight discomfort during the initial injections, but the procedure itself is virtually painless, allowing them to converse comfortably with the surgical team. Unlike major surgeries, general anesthesia is not required, making the procedure much safer with faster postoperative recovery.

Yes. Transplanted hair originates from strong follicles resistant to DHT, allowing for permanent regrowth.

Hair follicles harvested from the donor zone (posterior scalp) are genetically resistant to the miniaturizing effects of DHT, the primary factor in androgenetic alopecia. Once transplanted, these follicles retain their resistance and grow permanently in the new location. However, native non-transplanted hair remains susceptible to thinning, so adjunctive medical therapy is often recommended for optimal long-term density.

Recovery takes approximately 3–7 days, with minimal downtime. Most patients can resume daily activities quickly.

Most patients are able to return to light work within 2–3 days and resume normal routines within 5–7 days. Minor redness, swelling, or scabbing typically resolves within 7–10 days depending on individual healing. Strict adherence to postoperative care instructions provided by the surgeon ensures optimal healing and natural outcomes.

Transplanted hair is not affected by hormones or genetics, but surrounding native hair may still thin over time.

Follicles relocated from the donor zone remain resistant to DHT and will not undergo genetic thinning. However, existing native hair adjacent to the transplanted region may still miniaturize and shed. For this reason, continuing medical therapies such as Finasteride, Minoxidil, or Low-Level Laser Therapy (LLLT) is strongly advised to preserve native density and maintain natural, uniform results.

Candidates include individuals with genetic hair thinning, sufficient donor follicles, and good overall health.

Hair transplantation is best suited for patients with androgenetic alopecia who retain adequate donor hair in the occipital or parietal regions. Ideal candidates are in good general health, free from active scalp disease, and have realistic expectations. It is also indicated for scar revision, reconstruction after trauma, or correcting disproportionate hairlines.

Yes. Women with thinning from genetics, scarring, or localized alopecia may benefit from hair transplantation.

Although hair transplantation is most common in men, women can also undergo the procedure successfully, particularly when hair loss is due to female-pattern alopecia, scarring, or localized thinning. However, female hair loss may also result from hormonal imbalance, nutritional deficiency, or systemic disease. Comprehensive evaluation and accurate diagnosis are therefore essential prior to surgical intervention.

Generally age 25 and above, when hair loss patterns are more stable. In severe cases, younger candidates may be considered.

Hair transplantation is generally recommended for patients aged 25 years and older, as by this age the progression pattern of androgenetic alopecia is usually more predictable, allowing for precise surgical planning. In younger patients, conservative management with medical therapy or regenerative approaches may be more appropriate until hair loss stabilizes.

Yes. Medications help preserve native hair and maintain overall density.

While transplanted hair remains permanent, surrounding native hair continues to be vulnerable to DHT. Pharmacological agents such as Finasteride (oral 5-alpha-reductase inhibitor) and Minoxidil (topical vasodilator) play a crucial role in reducing further miniaturization, thickening existing hair, and supporting long-term density. These adjunctive therapies ensure that the final appearance remains natural and aesthetically balanced.

A hair transplant typically takes 4–8 hours, depending on graft numbers and surgical technique.

The duration varies with the number of follicular units transplanted and the method applied. For example, sessions involving 1,500–2,000 grafts usually last 4–6 hours, whereas megasessions exceeding 3,000 grafts may require 6–8 hours or more. The choice of technique—FUE, Direct Hair Implantation (DHI), or Long Hair FUE—also influences surgical time and efficiency.

Dr. Ben is a hair transplant surgeon with more than 15 years of experience, serving as the President of FUE Asia, internationally recognized for surgical excellence and quality outcomes.

Mediren Clinic is led by Dr. Ben Butwong (MD, ABHRS), who has practiced hair restoration for over 15 years. She specializes in advanced FUE techniques, Long Hair FUE, and FUE Megasession. Her approach emphasizes patient safety, artistry in natural hairline design, and long-term aesthetic results, helping patients regain both hair and confidence.

Dr. Ben has more than 15 years of experience, specializing in FUE, DHI, Long Hair FUE, and FUE Megasession.

Dr. Ben began practicing hair transplantation at the early introduction of FUE in Asia. Over the years, she has continuously advanced her expertise in complex procedures such as Long Hair FUE and high-volume FUE Megasession. To date, she has performed thousands of cases, both in Thailand and internationally, establishing her as a leading authority in the field.

Dr. Ben is an invited speaker at international hair transplant congresses and plays a leading role in academic advancement across Asia and beyond.

Dr. Ben Butwong has been repeatedly invited to lecture and present at global conferences such as FUE Asia, ISHRS, and regional scientific meetings in China, Indonesia, and Europe. She was also appointed Chairperson of FUE Asia 2024 in Bangkok, a prestigious recognition of her leadership and academic contributions. These roles highlight her reputation as a respected educator and thought leader in hair restoration.

Yes, Dr. Ben has been invited as a lecturer and speaker at multiple international conferences across Asia and Europe.

Dr. Ben is actively engaged in knowledge exchange on global platforms, regularly lecturing at academic meetings in China, Indonesia, India, and European countries. Through these international engagements, she contributes to elevating clinical standards in hair transplantation and represents Thailand as a trusted authority in the field.

Mediren Clinic stands out by being led by Dr. Ben Butwong, an internationally recognized surgeon, delivering superior quality and safety standards.

What sets Mediren Clinic apart is Dr. Ben’s internationally acknowledged expertise, refined artistry, and relentless commitment to precision. Her leadership combines extensive surgical experience with a personal dedication to patient-focused care. This meticulous approach ensures that each procedure, especially complex hair restoration surgeries, achieves results that are both natural and enduring. Patients and medical peers alike trust Mediren for its consistency and excellence.

Dr. Ben is renowned for FUE Megasession and Long Hair FUE, particularly in highly complex or advanced cases.

Dr. Ben has mastered Long Hair FUE and Mega Long Hair FUE, techniques that allow transplantation without full shaving. This enables patients to preview the immediate aesthetic outcome. Additionally, she excels in FUE Megasession, restoring extensive hair loss in a single high-density procedure. These advanced methods require exceptional surgical precision, high stamina, and a highly skilled team—qualities that distinguish Dr. Ben in the global hair transplant community.

Mediren Clinic adheres to global standards in sterilization, patient safety, and evidence-based hair transplant techniques.

The clinic is equipped with operating rooms and instruments that comply with international sterilization protocols. Instruments are sterilized through validated systems, and only certified surgical tools are used. The medical team is trained according to global hair restoration guidelines, ensuring both patient safety and optimal clinical outcomes.

Because Dr. Ben is internationally recognized and committed to honesty and evidence-based medical practice.

Mediren Clinic has earned patient trust by practicing with integrity, transparency, and rigorous adherence to medical standards. Dr. Ben ensures that patients are fully informed of both the benefits and limitations of hair restoration surgery. She avoids exaggerated advertising claims, relying instead on proven clinical outcomes and scientific credibility. This ethical approach has established the clinic’s reputation for excellence.

Yes. Patients receive comprehensive follow-up visits, medical advice, and supportive therapies after transplantation.

Post-operative care is an essential component of treatment at Mediren Clinic. Patients are scheduled for regular follow-up appointments to monitor graft survival and hair growth progress. Dr. Ben also advises on proper hair care, prescribes supportive medications, and may recommend Low-Level Laser Therapy (LLLT) to stimulate follicles. This comprehensive aftercare ensures the best long-term outcome and patient satisfaction.

Dr. Ben upholds the values of dedication, honesty, and artistry, aiming for safe, natural, and lasting results.

For Dr. Ben, hair transplantation is not merely a surgical procedure—it is a fusion of medicine and artistry. She believes in tailoring each hairline to the patient’s facial structure and personality. Her guiding principle is “commitment, transparency, and natural safety.” By combining technical precision with aesthetic vision, she ensures that patients not only regain their hair but also their confidence, self-image, and quality of life.

No hair transplant can achieve a true 100% result. Outcomes depend on the surgeon’s expertise, graft quality, and postoperative care.

Hair transplantation generally yields excellent outcomes but can never be guaranteed at 100%. Results vary based on the surgeon’s skill, the quality of donor follicles, the density required, the surgical technique, and patient compliance with postoperative care. Clinics that claim a “100% success rate” are typically engaging in misleading marketing. Patients should exercise caution and seek transparent, evidence-based information.

The new hairline is visible immediately, but transplanted hairs shed and regrow between 4–12 months.

Immediately after surgery, patients can see the newly implanted hairline and graft distribution. However, most transplanted hairs will enter a shedding phase within the first two months. True regrowth begins at around 4 months and continues to mature between 6–12 months. Patients should be informed that final outcomes require time and biological healing, not just the immediate postoperative appearance.

Excessively low prices often reflect compromises in surgical quality, surgeon expertise, team training, and patient safety.

The cost of hair transplantation depends on several factors: number of grafts, technique used (FUE, DHI, Long Hair FUE), surgical equipment, and physician experience. Abnormally low prices may indicate cost-cutting practices, such as replacing physicians with technicians, using inexperienced doctors, or substandard instruments. While some patients may see partial results, the hidden risk is irreversible damage to donor follicles—a nonrenewable resource.

Celebrity or influencer endorsements are marketing strategies, not medical guarantees.

Celebrity marketing builds consumer confidence but does not reflect medical reality. Hair transplant outcomes depend on the individual’s donor hair quality, scalp condition, and proper surgical planning. What works for one public figure may not apply to another patient. Choosing a surgeon with verifiable expertise and clinical outcomes is far more reliable than trusting promotional testimonials.

Hair transplantation involves mild discomfort and short recovery, though far less invasive than major surgery.

Claims of being “completely painless with no downtime” are exaggerated. Local anesthesia ensures minimal intraoperative pain, but patients may experience temporary swelling, tightness, or mild soreness afterward. True recovery typically requires 3–7 days, during which patients should avoid trauma to the grafts. While recovery is relatively quick, it is inaccurate to suggest there is “zero downtime.”

No serum can create immediate permanent hair growth; at best, they support hair health or delay shedding.

Many hair serums in the market claim to induce new hair growth. However, no peer-reviewed medical evidence supports the idea that serum alone can regenerate permanent hair follicles. Their benefits are usually limited to improving hair shaft quality, delaying hair loss, or thickening miniaturized hair. Genetic or advanced hair loss cannot be corrected by cosmetic serums and requires medical or surgical treatment.

Most online hair growth products are unregulated, potentially counterfeit, and carry safety risks.

Online markets are flooded with “hair growth” products, many of which lack approval from medical authorities (e.g., FDA, Thai FDA). Some may be counterfeit, contaminated, or contain unlisted harmful substances. Self-medicating with unverified drugs or supplements poses risks of allergic reactions, scalp damage, or systemic side effects. Safe treatment requires prescription-based medication and physician supervision.

Experienced technicians may have manual skill, but they lack the medical knowledge, accountability, and overall expertise of qualified physicians.

Technicians may develop dexterity in graft handling, but they are not trained to assess patient suitability, scalp physiology, donor capacity, or long-term safety. Moreover, technicians carry no medical liability for poor results. In contrast, a licensed and experienced physician is both accountable and trained to combine medical science with surgical artistry. For natural and safe outcomes, patients must choose a physician-led procedure, not a technician-dependent one.

Price differences depend on graft count, surgical technique, equipment, physician expertise, and marketing overhead.

Key factors influencing cost include:

• Number of grafts (accurately counted vs. over-claimed)

• Surgical method (FUE, DHI, Long Hair FUE)

• Sterilization standards and safety measures

• Physician experience and reputation

• Clinic overhead, including aggressive marketing budgets

Excessively low fees often compromise quality, while unreasonably high prices may reflect inflated marketing costs rather than medical superiority. Patients should evaluate value and safety, not price alone.

Low-cost procedures risk poor results, follicular damage, unnatural appearance, and medical complications.

Budget hair transplants often cut costs by using inexperienced doctors or delegating surgery to technicians (“learning by doing”). This can lead to:

• Permanent follicular damage

• Low graft survival rates

• Unnatural hairlines or poor density

• Postoperative complications such as infection, scarring, or shock loss

Investing in a reputable clinic and experienced physician ensures not only higher survival rates but also a natural, long-lasting aesthetic outcome—protecting patients from irreversible mistakes.

LLLT is a low-level laser that stimulates hair follicles. Some studies support its effects, but outcomes are less consistent than hair transplantation.

LLLT applies low-level laser light to the scalp to improve blood circulation and enhance energy production in follicular cells. Several studies suggest that it can help reduce shedding and improve hair thickness, particularly in early stages of hair loss. However, results are temporary, require ongoing sessions, and are not as definitive as surgical hair transplantation. It is best considered a supportive treatment rather than a primary solution.

There are several studies supporting LLLT, but limitations remain, and results vary between individuals.

Although published studies show that LLLT can reduce hair loss and increase hair counts, trial designs, patient groups, and methodologies differ significantly. This variation limits the strength of conclusions, and outcomes are not as predictable as medication or hair transplantation. Individual responses depend on genetics and scalp condition, making results inconsistent.

Treatment should be done 2–3 times per week for at least 3–6 months, though results may be modest.

LLLT requires strict consistency. Most guidelines recommend 2–3 sessions weekly for a minimum of 3–6 months before any visible improvement in hair density. Even then, results are often limited. If treatment is discontinued, benefits usually diminish because LLLT does not address the root cause of androgenetic alopecia.

LLLT may be worthwhile for early hair loss, mainly for supportive and psychological benefits, but it is not a definitive treatment.

LLLT is moderately priced compared with other treatments. It may be suitable for patients with early thinning who wish to slow shedding, particularly if they are not ready for transplantation. However, its effectiveness is limited, requires ongoing sessions, and does not provide long-term correction. For patients seeking permanent results, hair transplantation is generally more cost-effective in the long run.

PRP uses concentrated platelets from a patient’s own blood to stimulate follicles. Some studies support it, but results are inconsistent and not definitive.

PRP involves drawing a patient’s blood, centrifuging it to obtain platelet-rich plasma, and injecting it into the scalp. Theoretically, growth factors released from platelets can stimulate follicular activity. Certain studies report improvements in hair thickness and shedding, but outcomes are variable and not yet reliable. Importantly, in Thailand, the Medical Council has not formally endorsed PRP as an approved treatment for hair restoration.

Finasteride and Minoxidil usually provide more consistent long-term results than PRP.

Comparative studies show that oral Finasteride and topical Minoxidil remain the gold-standard therapies for androgenetic alopecia, producing more reliable outcomes than PRP. While PRP may offer additional benefit for some patients, it should be regarded as an adjunctive option—particularly in patients who cannot tolerate or decline medication—rather than a replacement.

Because PRP is not standardized, results differ depending on platelet quality, processing methods, and follicle health.

The concentration of platelets and growth factors depends on the patient’s baseline blood characteristics and the centrifugation method used, which varies among clinics. Additionally, follicular condition—such as miniaturization stage and overall scalp health—affects responsiveness. Since PRP protocols are not yet standardized and evidence remains weak, outcomes range from mild improvement to no response at all.

Exosome Therapy uses cell-derived signaling particles to stimulate hair follicles. It remains experimental.

Exosome Therapy involves extracellular vesicles secreted by stem cells, rich in proteins and biomolecules that may promote follicle repair and regeneration. Early laboratory and clinical reports show potential, but the therapy is still in the research phase, lacks standardization, and has not been formally approved by regulatory authorities. At present, it should be considered experimental rather than established treatment.

Because regenerative therapies stimulate existing follicles but cannot create new permanent follicles like transplantation.

Regenerative approaches—such as PRP, LLLT, exosome therapy, or growth factor injections—aim to revitalize follicles that are still alive, but cannot replace follicles that are already destroyed. In contrast, hair transplantation involves relocating healthy, DHT-resistant follicles to bald areas, ensuring permanent growth. This is why regenerative therapies cannot serve as a substitute for surgical transplantation in advanced cases.

Patients should expect slowed shedding or modest thickening, but results may be minimal or absent in some cases.

Regenerative treatments are best for early-stage hair loss. They may improve hair quality, slow further loss, and provide some thickening. However, patients must understand that results are limited, temporary, and vary widely—ranging from slight improvement to no effect at all. They should not expect the level of density or permanence achievable with transplantation. Clear expectations help ensure patient satisfaction and informed decision-making.

Nanofat uses adipose-derived cells to stimulate hair follicles. Evidence is limited, results are unclear, and cost-effectiveness is low.

Nanofat involves harvesting a small amount of fat through liposuction, processing it into an injectable form containing regenerative cells and biomolecules, and injecting it into the scalp to stimulate follicles. However, clinical research is scarce, results are inconsistent, and in some patients ineffective. Thus, Nanofat should be regarded as an adjunctive, experimental therapy with limited cost-effectiveness, not a reliable primary treatment.

Only a few preliminary studies suggest Nanofat may increase hair density. Evidence is insufficient, and it is not a standard therapy.

Some small-scale studies have reported potential improvements in hair density and quality after Nanofat injection, especially in early-stage alopecia. However, the number of studies is very limited, sample sizes are small, and outcomes are inconsistent. In real-world practice, results are often minimal or absent. Therefore, Nanofat remains an experimental supportive therapy, not a standardized treatment.

Stem cell therapy for hair loss is not a recognized standard. It remains experimental and under clinical investigation.

Although stem cells are widely studied in regenerative medicine, their use in hair restoration has not yet reached scientific consensus. There is insufficient evidence to prove long-term or permanent results. At present, stem cell therapy for hair loss is still considered experimental and has not been approved by major regulatory or medical bodies.

Stem cells may come from adipose tissue or blood, but safety and efficacy standards are not yet established.

Most stem cells used in hair-related therapies are derived from adipose tissue (adipose-derived stem cells) or peripheral blood. However, preparation methods vary among clinics, leading to inconsistency in quality and effectiveness. While procedures are generally safe when performed by trained professionals, the absence of international regulatory standards means patients should proceed with caution and fully understand the limitations.

Because there is a lack of large-scale, long-term studies and no global regulatory approval.

Current evidence comes mostly from small pilot studies with limited follow-up, producing inconsistent results. The long-term efficacy and safety of stem cell therapy in hair restoration remain unknown. Additionally, it has not been approved by leading regulatory agencies such as the FDA or EMA, which is why it continues to be classified as experimental rather than standard therapy.

Growth Factor injections may stimulate follicles but lack strong evidence for permanent results.

Growth Factor therapy involves injecting bioactive molecules such as VEGF, bFGF, or PDGF, aiming to enhance follicular cell proliferation and repair. Some early studies report positive effects in reducing hair shedding and improving thickness. However, long-term and permanent outcomes have not been scientifically proven. It should be viewed as a supportive measure rather than a replacement for transplantation or evidence-based medication.

IGF promotes the hair growth cycle by strengthening follicles and prolonging the anagen phase.

IGF is a protein with a key role in cell growth and repair, including follicular activity. Laboratory studies show IGF can stimulate follicular keratinocyte proliferation and extend the anagen (growth) phase of hair. However, the clinical use of IGF injections for hair loss remains experimental, with no established protocols or standardized outcomes in practice.

Vitamin injections may provide mild nourishment but do not treat genetic hair loss. They are largely marketing-driven.

Injections of vitamins such as Biotin or multivitamin blends may improve scalp condition and hair shaft quality. However, they do not address androgenetic alopecia, which is hormonally driven by DHT. Results are usually limited to cosmetic support rather than therapeutic correction. As such, vitamin injections are considered more of a commercial add-on than a core medical treatment.

Differences are due to follicular health, genetics, and individual biological response.

Patient outcomes depend on multiple factors: the baseline strength of hair follicles, age, genetic predisposition, and scalp condition. Some individuals respond well, showing thicker hair, while others experience no visible improvement. This variability underscores the fact that Growth Factor and vitamin injections are not standardized therapies and should not be expected to work equally in all patients.

For definitive results, transplantation is the gold standard. Regenerative injections are temporary and best used as supportive therapy.

Hair transplantation involves relocating strong, DHT-resistant follicles, providing a permanent correction for hair loss. Regenerative treatments such as PRP, Nanofat, stem cell injections, or Growth Factors may slow shedding and improve existing follicle health, but their results are temporary and inconsistent. The choice depends on patient goals and budget, but for long-term, reliable outcomes, surgical hair transplantation remains the primary treatment.

ISHRS membership indicates enrollment in a private international society; it does not guarantee surgical skill.

The International Society of Hair Restoration Surgery (ISHRS) is a private professional society. Physicians can apply and maintain membership by meeting basic criteria and paying annual dues. Membership signals interest in hair restoration but does not, by itself, attest to hands-on proficiency or surgical outcomes. Patients should evaluate a surgeon’s real-world experience and case results alongside society memberships.

ISHRS does not test surgical skills; it primarily verifies physician identity and membership criteria.

Unlike certain board certifications, ISHRS membership does not require a technical skills examination. The society confirms baseline physician credentials and dues but does not function as a competency certification. It provides access to education and meetings rather than vouching for operative skill.

Membership requires application and fees and some other criteria ; formal, standardized surgical training is not mandatory.

To join ISHRS, physicians provide documentation per society criteria and pay membership dues. Documented case numbers or supervised operative training are not a core requirement for admission. Therefore, membership should not be advertised as a direct proxy for surgical mastery.

ABHRS conducts a private credentialing exam; like ISHRS, it is a private organization.

The American Board of Hair Restoration Surgery (ABHRS) is a private body administering an examination process leading to the “Diplomate” credential. It may include case submissions and written/oral exams. However, it is not a government-regulated medical board, and thus should be viewed as a private credentialing pathway, distinct from state or national licensure/board systems.

ABHRS involves exams and case submissions but does not equate to standardized residency-style training.

Candidates submit cases and pass written/oral components. There is no universal, centrally supervised practical training program akin to a formal residency. While the credential reflects engagement and knowledge, it does not automatically confirm extensive hands-on proficiency comparable to long-term mentored surgical training.

Concerns exist that submitted cases may not always represent the applicant’s exclusively performed work.

Within the field, there have been periodic concerns that some submitted cases may involve collaborative or team-based contributions, complicating attribution. This limitation means case submissions do not invariably prove 100% personal operative execution.

Often it refers to a short course rather than a full, intensive degree program in hair transplantation.

In many advertisements, “King’s College” or comparable brands indicate attendance at short courses or CPD workshops open to physicians internationally. These are valuable educational exposures but not equivalent to full-length, competency-based programs with extensive hands-on training. Patients should ask which program, duration, and scope were completed.

Board certification reflects specialty clinical training; a Master’s degree is academic and not a clinical specialty board.

A board-certified dermatologist completes a structured specialty training program with clinical rotations and a formal board examination recognized by medical councils. A Master’s degree is primarily academic/research-focused and does not, by itself, confer specialty clinical certification. Their implications for procedural experience therefore differ substantially.

Typically, no—comprehensive hair transplant training is not a core part of standard curricula.

Traditional dermatology and plastic surgery training focuses on broad skin disease, reconstruction, and cosmetic surgery. Dedicated, high-volume hair transplant training is often limited, with restricted exposure to modern FUE/DHI/Long-Hair techniques. True mastery generally requires additional focused training and substantial case volume over time.

Limited patient volume can restrict intensive hands-on experience.

While such programs are a positive development, a limited number of live surgical cases may hinder comprehensive exposure to diverse scenarios (e.g., scar tissue, advanced alopecia, repair work, megasessions). Graduates may need further proctorship and case accumulation to achieve consistent, high-level outcomes.

Because elective hair transplantation attracts fewer training-eligible patients.

Unlike high-throughput hospital specialties, hair transplantation is an elective, niche procedure. Patient numbers suitable for supervised training can be limited, reducing breadth of technique exposure (e.g., varied donor characteristics, hair types, densities).

Not automatically; additional focused training and substantial case experience are required.

Such credentials validate specialty knowledge but do not directly equate to hair restoration expertise. Hair transplantation requires microsurgical precision, artistic hairline design, donor management, and long-term planning, skills that develop through dedicated training and high case volumes under expert supervision.

Evaluate real case experience, verifiable outcomes, and transparent patient counseling.

Patients should review case portfolios with consistent, natural results, confirm accurate graft counts and postoperative follow-up, seek independent reviews/testimonials, and observe whether the surgeon communicates benefits and limitations honestly. Emphasize track record and transparency over marketing claims or society logos alone.